Sadikot's International Textbook of Diabetes
Autor Kamlakar Tripathi, Banshi Saboo, Amit Guptaen Limba Engleză Paperback – 10 aug 2024
Comprising 150 chapters, the text begins with an overview of the history, epidemiology and pathogenesis of the disease. The next chapters discuss different types of diabetes, diagnosis, management techniques, monitoring, and chronic and acute complications.
Individual chapters are dedicated to diabetes in special situations such as in pregnancy, with drug addiction, eating disorders, and during Ramadan.
The successful first edition of this book has been fully revised and extended to provide clinicians with the latest advances and technologies in the field. Many new topics have been added to the second edition.
The comprehensive text is further enhanced by clinical photographs, diagrams and exhaustive references.
The previous edition (9789352700325) published in 2019.
Preț: 656.57 lei
Preț vechi: 840.14 lei
-22% Nou
Puncte Express: 985
Preț estimativ în valută:
125.65€ • 130.52$ • 104.37£
125.65€ • 130.52$ • 104.37£
Carte indisponibilă temporar
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789354659867
ISBN-10: 9354659861
Pagini: 1274
Dimensiuni: 171 x 241 x 43 mm
Ediția:2
Editura: Jp Medical Ltd
Colecția Jaypee Brothers Medical Publishers
Locul publicării:Delhi, India
ISBN-10: 9354659861
Pagini: 1274
Dimensiuni: 171 x 241 x 43 mm
Ediția:2
Editura: Jp Medical Ltd
Colecția Jaypee Brothers Medical Publishers
Locul publicării:Delhi, India
Cuprins
1. History of Diabetes
2. Diagnosis and Classification of Diabetes
3. Clustering of Type 2 Diabetes
4. Epidemiology of Type 2 Diabetes
5. Epidemiology of Type 1 Diabetes
6. The Management of Type 1 Diabetes in Adults
7. Epidemiology of Gestational Diabetes Mellitus
8. Anatomy of Beta Cell: In Health and Disease
9. Carbohydrate, Lipids, Protein–Normal Metabolism
10. Role of Liver in Glucose Metabolism (MASLD/MASH)
11. Insulin Structure, Biosynthesis, Secretion, and Action of Insulin
12. Biological Effects of C‐peptide and Proinsulin
13. Biosynthesis, Secretion, and Action of Glucagon
14. Associated and Causative Genes or Variants in Diabetes
15. Autoimmunity and Diabetes
16. Molecular Pathogenesis of Type 2 Diabetes
17. Gut Microbiome and Diabetes: An Untold Story
18. Monogenic Diabetes
19. Insulin Intensification
20. Endocrine Disease and Diabetes
21. Pancreatic Disease and Diabetes
22. Hereditary and Acquired Syndrome in Diabetes
23. Stress-induced Diabetes
24. Interplay of Neuroendocrine and Autonomic Factors in Diabetes Mellitus
25. Type 2 Diabetes: “Thrifty Genotype” or a “Thrifty Phenotype”?
26. Sarcopenia and Diabetes: A Lethal Conjunction
27. Weight Modulation with Glucose Lowering Drugs
28. Bariatric Surgery
29. Self-monitoring of Blood Glucose
30. Continuous Glucose Monitoring: A Comprehensive Guide towards Better Understanding CGM and AGP
31. Long Term Glycemic Monitoring
32. Monitoring Microvascular Complications
33. Monitoring Macrovascular Complications of Diabetes
34. Nuclear Medicine and Diabetes
35. Noninvasive Glucose Monitoring
36. Therapeutic Patient Education
37. Effect of Exercise and Yoga
38. Dietary Management
39. Stress in Diabetes and Its Management
40. Nutraceuticals in Diabetes
41. Sulfonylureas
42. Re-emerging Role of Sulfonylureas in Alpha-Beta Cell Preservation
43. Meglitinides
44. Metformin
45. Thiazolidinedione as PPAR Agonist
46. Alpha-glucosidase Inhibitors
47. DPP-4 Inhibitors
48. Glucagon-like Peptide-1 Receptor Agonist
49. SGLT-2 Inhibitors
50. Initial Combination Therapy for Management of Glycemia in Adults with New-onset Type 2 Diabetes Mellitus
51. Insulin Taxonomy
52. Insulin Initiation: Choosing the Regimen
53. Combining Insulin with Oral Antidiabetic Agents
54. GLP-1 RA and Insulin Combination
55. Insulin Therapy in Renal and Hepatic Diseases
56. Insulin Technique
57. Noninjectable Insulins
58. Insulin Analogues
59. Future Generations of Insulin
60. Epidemiology of Diabetic Microvascular Complications and their Relation with Glycemic Control
61. Advances in Insulin Therapy and Insulin Futures
62. Pathogenesis and Management of Diabetes Eye Disease Including Nonretinal Ocular Complications
63. Future Prospects in Screening for Diabetic Retinopathy
64. Management of Diabetic Neuropathy
65. Diabetic Autonomic Neuropathy
66. Pathogenesis and Management of Diabetic Nephropathy
67. Nondiabetic Kidney Disease in Diabetes Mellitus
68. Management of Diabetes in End-stage Renal Disease
69. Epidemiology of Macrovascular Disease and Effect of Intensive Diabetes Control on Macrovascular Events
70. Cardiometabolic Risk
71. Insulin Resistance, Metabolic Stress, Endothelial Dysfunction, and Atherosclerosis
72. Lipid Disorders in Diabetes
73. Hypertension in Diabetes
74. Diabetes and Coronary Artery Disease
75. Diabetes and Heart Failure
76. Diabetes and Cerebrovascular Disease
77. Use of Oral Antithrombotic in Diabetic Macrovascular Complications
78. Diabetes and Peripheral Vascular Disease
79. Oral Cavity and Diabetes
80. Diabetic Hepatopathy, Steatohepatitis and Gastrointestinal Disorders in Diabetes
81. Rheumatological Manifestations in Diabetes
82. Diabetes and Cancer: Direct Link and Indirect Link Through Oral Anti-diabetic Drugs
83. Anemia in Diabetes
84. Diabetes and Sexual Dysfunctions
85. Polycystic Ovary Syndrome and Diabetes
86. Skin Disorders in Diabetes
87. Epidemiology of Diabetes and Multimorbidity
88. Differences in Cardiac and Renal Protection with SGLT-2 Inhibitors
89. Hypoglycaemia
90. Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State
91. Glycemic Monitoring during Labor
92. Perioperative Management of Hyperglycemia
93. Management of In-hospital Hyperglycemia
94. Tuberculosis and Diabetes Mellitus
95. HIV/AIDS and Diabetes
96. Urogenital Infections in Diabetes
97. Other Infections in Diabetes
98. Surgical Anatomy and Biomechanics of Foot
99. Epidemiology and Pathogenesis of Diabetic Foot Ulcer
100. Clinical Approach to a Patient of Diabetic Foot and Evaluation Technique
101. Surgical Management of Diabetic Foot
102. Management of Diabetic Foot Infections
103. Day-to-day Foot Care in Diabetes
104. Preconception Management of Diabetes
105. Pharmacological Therapy in Diabetes Mellitus
106. Obstetrical Management of Gestational Diabetes Mellitus
107. Postpartum Management of Diabetes
108. Diabetes in Adolescents
109. Hypogonadotropic: Hypogonadism in Men with Type 2 Diabetes Mellitus
110. Diabetes and Menopause
111. Diabetes in Women
112. Diabetes in Elderly
113. Use of Artificial Intelligence in Diabetes Space Today
114. Ramadan Specific Diabetes Education
115. Nonpharmacological Therapy in Ramadan
116. Oral Glucose-lowering Therapy in Ramadan
117. Insulin Therapy in Ramadan
118. Continuous Subcutaneous Insulin Infusion Pump
119. Immunotherapy for Diabetes
120. Islet Cell Transplant and Pancreatic Transplantation
121. Gene Therapy versus Stem Cell Therapy in Management of Diabetes Mellitus
122. Role of Electronic Medical Records, Gadgets, Social Media, and Mobile App in Diabetes Care
123. Clinical Inertia
124. Diabetes Distress
125. Diabetes and Mental Health
126. Anxiety and Depressive Disorders in Diabetes
127. Eating Disorders and Diabetes
128. Drug Addiction and Diabetes
129. Employment and Diabetes
130. Travel and Diabetes
131. Sports and Diabetes
132. Marriage, Sexuality and Diabetes
133. Diabetes Advocacy: A Plea for Patients
134. Prevention of Diabetes
135. Global Organizations: Focus on Diabetes
136. Indian National Programmes and Policy Decisions for Diabetes
137. National List of Essential Medicines and Accessibility to Antidiabetic Drug in India: A Review
138. Economic Burden of Diabetes
139. Health Insurance and Diabetes
140. Health Economic of Anti-diabetic Therapy
141. Affordable Diabetes Care: Indian Public Health Standards
142. Biosimilars and Generics
143. Parent and Patient Education in Type 1 Diabetes
144. Diabetes Self-management: A Compilation of the Current Evidence and Practices
145. Motivational Interviewing in Diabetes Care
146. Religion as a Motivator for Diabetes Care
147. Novel Subgroups and Clustering in Diabetes
148. Management of Diabetes during Disaster
149. Diabetes Reversibility
150. Role of Imaging in Management of Complications Associated with Diabetes Mellitus Patients
2. Diagnosis and Classification of Diabetes
3. Clustering of Type 2 Diabetes
4. Epidemiology of Type 2 Diabetes
5. Epidemiology of Type 1 Diabetes
6. The Management of Type 1 Diabetes in Adults
7. Epidemiology of Gestational Diabetes Mellitus
8. Anatomy of Beta Cell: In Health and Disease
9. Carbohydrate, Lipids, Protein–Normal Metabolism
10. Role of Liver in Glucose Metabolism (MASLD/MASH)
11. Insulin Structure, Biosynthesis, Secretion, and Action of Insulin
12. Biological Effects of C‐peptide and Proinsulin
13. Biosynthesis, Secretion, and Action of Glucagon
14. Associated and Causative Genes or Variants in Diabetes
15. Autoimmunity and Diabetes
16. Molecular Pathogenesis of Type 2 Diabetes
17. Gut Microbiome and Diabetes: An Untold Story
18. Monogenic Diabetes
19. Insulin Intensification
20. Endocrine Disease and Diabetes
21. Pancreatic Disease and Diabetes
22. Hereditary and Acquired Syndrome in Diabetes
23. Stress-induced Diabetes
24. Interplay of Neuroendocrine and Autonomic Factors in Diabetes Mellitus
25. Type 2 Diabetes: “Thrifty Genotype” or a “Thrifty Phenotype”?
26. Sarcopenia and Diabetes: A Lethal Conjunction
27. Weight Modulation with Glucose Lowering Drugs
28. Bariatric Surgery
29. Self-monitoring of Blood Glucose
30. Continuous Glucose Monitoring: A Comprehensive Guide towards Better Understanding CGM and AGP
31. Long Term Glycemic Monitoring
32. Monitoring Microvascular Complications
33. Monitoring Macrovascular Complications of Diabetes
34. Nuclear Medicine and Diabetes
35. Noninvasive Glucose Monitoring
36. Therapeutic Patient Education
37. Effect of Exercise and Yoga
38. Dietary Management
39. Stress in Diabetes and Its Management
40. Nutraceuticals in Diabetes
41. Sulfonylureas
42. Re-emerging Role of Sulfonylureas in Alpha-Beta Cell Preservation
43. Meglitinides
44. Metformin
45. Thiazolidinedione as PPAR Agonist
46. Alpha-glucosidase Inhibitors
47. DPP-4 Inhibitors
48. Glucagon-like Peptide-1 Receptor Agonist
49. SGLT-2 Inhibitors
50. Initial Combination Therapy for Management of Glycemia in Adults with New-onset Type 2 Diabetes Mellitus
51. Insulin Taxonomy
52. Insulin Initiation: Choosing the Regimen
53. Combining Insulin with Oral Antidiabetic Agents
54. GLP-1 RA and Insulin Combination
55. Insulin Therapy in Renal and Hepatic Diseases
56. Insulin Technique
57. Noninjectable Insulins
58. Insulin Analogues
59. Future Generations of Insulin
60. Epidemiology of Diabetic Microvascular Complications and their Relation with Glycemic Control
61. Advances in Insulin Therapy and Insulin Futures
62. Pathogenesis and Management of Diabetes Eye Disease Including Nonretinal Ocular Complications
63. Future Prospects in Screening for Diabetic Retinopathy
64. Management of Diabetic Neuropathy
65. Diabetic Autonomic Neuropathy
66. Pathogenesis and Management of Diabetic Nephropathy
67. Nondiabetic Kidney Disease in Diabetes Mellitus
68. Management of Diabetes in End-stage Renal Disease
69. Epidemiology of Macrovascular Disease and Effect of Intensive Diabetes Control on Macrovascular Events
70. Cardiometabolic Risk
71. Insulin Resistance, Metabolic Stress, Endothelial Dysfunction, and Atherosclerosis
72. Lipid Disorders in Diabetes
73. Hypertension in Diabetes
74. Diabetes and Coronary Artery Disease
75. Diabetes and Heart Failure
76. Diabetes and Cerebrovascular Disease
77. Use of Oral Antithrombotic in Diabetic Macrovascular Complications
78. Diabetes and Peripheral Vascular Disease
79. Oral Cavity and Diabetes
80. Diabetic Hepatopathy, Steatohepatitis and Gastrointestinal Disorders in Diabetes
81. Rheumatological Manifestations in Diabetes
82. Diabetes and Cancer: Direct Link and Indirect Link Through Oral Anti-diabetic Drugs
83. Anemia in Diabetes
84. Diabetes and Sexual Dysfunctions
85. Polycystic Ovary Syndrome and Diabetes
86. Skin Disorders in Diabetes
87. Epidemiology of Diabetes and Multimorbidity
88. Differences in Cardiac and Renal Protection with SGLT-2 Inhibitors
89. Hypoglycaemia
90. Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State
91. Glycemic Monitoring during Labor
92. Perioperative Management of Hyperglycemia
93. Management of In-hospital Hyperglycemia
94. Tuberculosis and Diabetes Mellitus
95. HIV/AIDS and Diabetes
96. Urogenital Infections in Diabetes
97. Other Infections in Diabetes
98. Surgical Anatomy and Biomechanics of Foot
99. Epidemiology and Pathogenesis of Diabetic Foot Ulcer
100. Clinical Approach to a Patient of Diabetic Foot and Evaluation Technique
101. Surgical Management of Diabetic Foot
102. Management of Diabetic Foot Infections
103. Day-to-day Foot Care in Diabetes
104. Preconception Management of Diabetes
105. Pharmacological Therapy in Diabetes Mellitus
106. Obstetrical Management of Gestational Diabetes Mellitus
107. Postpartum Management of Diabetes
108. Diabetes in Adolescents
109. Hypogonadotropic: Hypogonadism in Men with Type 2 Diabetes Mellitus
110. Diabetes and Menopause
111. Diabetes in Women
112. Diabetes in Elderly
113. Use of Artificial Intelligence in Diabetes Space Today
114. Ramadan Specific Diabetes Education
115. Nonpharmacological Therapy in Ramadan
116. Oral Glucose-lowering Therapy in Ramadan
117. Insulin Therapy in Ramadan
118. Continuous Subcutaneous Insulin Infusion Pump
119. Immunotherapy for Diabetes
120. Islet Cell Transplant and Pancreatic Transplantation
121. Gene Therapy versus Stem Cell Therapy in Management of Diabetes Mellitus
122. Role of Electronic Medical Records, Gadgets, Social Media, and Mobile App in Diabetes Care
123. Clinical Inertia
124. Diabetes Distress
125. Diabetes and Mental Health
126. Anxiety and Depressive Disorders in Diabetes
127. Eating Disorders and Diabetes
128. Drug Addiction and Diabetes
129. Employment and Diabetes
130. Travel and Diabetes
131. Sports and Diabetes
132. Marriage, Sexuality and Diabetes
133. Diabetes Advocacy: A Plea for Patients
134. Prevention of Diabetes
135. Global Organizations: Focus on Diabetes
136. Indian National Programmes and Policy Decisions for Diabetes
137. National List of Essential Medicines and Accessibility to Antidiabetic Drug in India: A Review
138. Economic Burden of Diabetes
139. Health Insurance and Diabetes
140. Health Economic of Anti-diabetic Therapy
141. Affordable Diabetes Care: Indian Public Health Standards
142. Biosimilars and Generics
143. Parent and Patient Education in Type 1 Diabetes
144. Diabetes Self-management: A Compilation of the Current Evidence and Practices
145. Motivational Interviewing in Diabetes Care
146. Religion as a Motivator for Diabetes Care
147. Novel Subgroups and Clustering in Diabetes
148. Management of Diabetes during Disaster
149. Diabetes Reversibility
150. Role of Imaging in Management of Complications Associated with Diabetes Mellitus Patients
Notă biografică
Kamlakar Tripathi MD DM DNB MNAMS (Nephrology) FICP FFRSSDI FISH FUPDA FIAMS FRCP (Edinburgh)
Former Professor and Head, Department of Medicine, Banaras Hindu University Varanasi, Uttar Pradesh, India; Padma Shri Awardee 2022
Banshi Saboo MD PhD DSc FRCP MNAMS Fellow American College of Endocrinology (FACE) Fellow International College of Nutrition (FICN, Canada)
Diabetologist and Metabolic Physician DIACARE (Diabetes Care and Hormone Clinic), Ahmedabad, Gujarat, India; Honorary Secretary, Diabetes India
Amit Gupta DNB (General Medicine) MNAMS FACE FICP FRCP (Glasgow, Edinburgh) FACP FRSSDI F-Diab
Joint Secretary, Diabetes India; Diabetologist and Metabolic Physican, Medical Director, Centre for Diabetes Care, Greater Noida, Uttar Pradesh, India
Former Professor and Head, Department of Medicine, Banaras Hindu University Varanasi, Uttar Pradesh, India; Padma Shri Awardee 2022
Banshi Saboo MD PhD DSc FRCP MNAMS Fellow American College of Endocrinology (FACE) Fellow International College of Nutrition (FICN, Canada)
Diabetologist and Metabolic Physician DIACARE (Diabetes Care and Hormone Clinic), Ahmedabad, Gujarat, India; Honorary Secretary, Diabetes India
Amit Gupta DNB (General Medicine) MNAMS FACE FICP FRCP (Glasgow, Edinburgh) FACP FRSSDI F-Diab
Joint Secretary, Diabetes India; Diabetologist and Metabolic Physican, Medical Director, Centre for Diabetes Care, Greater Noida, Uttar Pradesh, India
Descriere
This book is a complete guide to the diagnosis and management of diabetes. Comprising 150 chapters, the text begins with an overview of the history, epidemiology and pathogenesis of the disease. The next chapters discuss different types of diabetes, diagnosis, management techniques, monitoring, and chronic and acute complications. Individual chapters are dedicated to diabetes in special situations such as in pregnancy, with drug addiction, eating disorders, and during Ramadan.